These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9691193)

  • 1. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants.
    Drago J; Padungchaichot P; Accili D; Fuchs S
    Dev Neurosci; 1998; 20(2-3):188-203. PubMed ID: 9691193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.
    Wong JY; Padungchaichot P; Massalas JS; Drago J
    Neuroscience; 2000; 95(4):1035-41. PubMed ID: 10682710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
    Morice E; Denis C; Giros B; Nosten-Bertrand M
    Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter.
    Tan S; Hermann B; Borrelli E
    Int Rev Neurobiol; 2003; 54():145-97. PubMed ID: 12785287
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mutant NMDA receptors in dopamine D1 receptor-containing cells prevents cocaine sensitization and decreases cocaine preference.
    Heusner CL; Palmiter RD
    J Neurosci; 2005 Jul; 25(28):6651-7. PubMed ID: 16014726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice in drug dependence research.
    Pich EM; Epping-Jordan MP
    Ann Med; 1998 Aug; 30(4):390-6. PubMed ID: 9783838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter.
    Spielewoy C; Biala G; Roubert C; Hamon M; Betancur C; Giros B
    Psychopharmacology (Berl); 2001 Dec; 159(1):2-9. PubMed ID: 11797063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Sadile AG
    Neurosci Biobehav Rev; 2003 Nov; 27(7):623-37. PubMed ID: 14624807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine self-administration in dopamine-transporter knockout mice.
    Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
    Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice.
    Hanania T; Zahniser NR
    Alcohol Clin Exp Res; 2002 Apr; 26(4):431-40. PubMed ID: 11981117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dopamine receptor knockout mice].
    Aiba A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Dec; 19(5):251-5. PubMed ID: 10803208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
    Giros B; Jaber M; Jones SR; Wightman RM; Caron MG
    Nature; 1996 Feb; 379(6566):606-12. PubMed ID: 8628395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms underlying the rewarding effects of cocaine.
    Hall FS; Sora I; Drgonova J; Li XF; Goeb M; Uhl GR
    Ann N Y Acad Sci; 2004 Oct; 1025():47-56. PubMed ID: 15542699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.
    Volkow ND; Fowler JS; Wang GJ
    J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo regulation of central nervous system progesterone receptors: cocaine induces steroid-dependent behavior through dopamine transporter modulation of D5 receptors in rats.
    Apostolakis EM; Garai J; Clark JH; O'Malley BW
    Mol Endocrinol; 1996 Dec; 10(12):1595-604. PubMed ID: 8961269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation].
    Jaber M; Bloch B; Caron MG; Giros B
    C R Seances Soc Biol Fil; 1998; 192(6):1127-37. PubMed ID: 10101608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function.
    Leslie CA; Robertson MW; Jung AB; Liebermann J; Bennett JP
    Synapse; 1994 Jul; 17(3):210-5. PubMed ID: 7974205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine transporter: a crucial component regulating dopamine transmission.
    Jaber M; Jones S; Giros B; Caron MG
    Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice.
    Powell SB; Lehmann-Masten VD; Paulus MP; Gainetdinov RR; Caron MG; Geyer MA
    Psychopharmacology (Berl); 2004 May; 173(3-4):310-7. PubMed ID: 14747902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.